Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels

Experimental Gerontology

Volumn 40, Issue 7, 2005, Pages 612-614

  Gangemi, Sebastiano ^a   Pescara, Lea ^b   D'Urbano, Etrusca ^b   Basile, Giorgio ^a   Nicita Mauro, Vittorio ^a   Davì, Giovanni ^b   Romano, Mario ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Inflammation; Leukotrienes; Lipoxins; Resolution

Indexed keywords

ARACHIDONIC ACID; LIPOXIN A; PEPTIDOLEUKOTRIENE;

ADULT; AGED; AGING; ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; URINALYSIS; VALIDATION PROCESS;

ADULT; AGING; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; FEMALE; HUMANS; LEUKOTRIENES; LIPOXINS; MALE; MIDDLE AGED;

EID: 23044433338     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2005.04.004     Document Type: Article

References (14)

1. 4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells J. Immunol. 170 2003 6266 6272
2. J.H. Dwyer, H. Allayee, K.M. Dwyer, J. Fan, H. Wu, R. Mar, A.J. Lusis, and M. Mehrabian Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis N. Engl. J. Med. 350 2004 29 37
3. W.B. Ershler, and E.T. Keller Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty Annu. Rev. Med. 51 2000 245 270
4. W.B. Ershler, and E.T. Keller Extraction techniques for lipoxins Lab. Invest. 82 2002 1253 1254
5. D.W. Gilroy, T. Lawrence, M. Perretti, and A.G. Rossi Inflammatory resolution: new opportunities for drug discovery Nat. Rev. Drug Discov. 3 2004 401 416
6. K. Gronert, T. Martinsson-Niskanen, S. Ravasi, N. Chiang, and C.N. Serhan Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses Am. J. Pathol. 158 2001 3 9
7. Y. Kanaoka, and J.A. Boyce Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses J. Immunol. 173 2004 1503 1510
8. C.L. Karp, L.M. Flick, K.W. Park, S. Softic, T.M. Greer, R. Keledjian, R. Yang, J. Uddin, W.B. Guggino, S.F. Atabani, Y. Belkaid, Y. Xu, J.A. Whitsett, F.J. Accurso, M. Wills-Karp, and N.A. Petasis Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway Nat. Immunol. 5 2004 388 392
9. B.D. Levy, C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan Lipid mediator class switching during acute inflammation: signals in resolution Nat. Immunol. 7 2001 612 619
10. B. McMahon, and C. Godson Lipoxins: endogenous regulators of inflammation Am. J. Physiol. Ren. Physiol. 286 2004 F189 F201
11. M. Mishto, A. Santoro, E. Bellavista, M. Bonafè, D. Monti, and C. Franceschi Immunoproteasomes and immunosenescence Ageing Res. Rev. 2 2003 419 432
12. 4 and related compounds: development of new extraction techniques for lipoxins Lab. Invest. 82 2002 1253 1254
13. T. Takano, S. Fiore, J.F. Maddox, H.R. Brady, N.A. Petasis, and C.N. Serhan Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors J. Exp. Med. 185 1997 1693 1704
14. I. Vachier, C. Bonnans, C. Chavis, M. Farce, P. Godard, J. Bousquet, and P. Chanez Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound J. Allergy Clin. Immunol. 115 2005 55 60